Product
TA-CIN
1 clinical trial
2 indications
Indication
ASC-USClinical trial
Phase I Clinical Trial Assessing the Safety and Feasibility of Intramuscular pNGVL4aCRTE6E7L2 and TA-CIN Administration for the Treatment of Patients With Persistent HPV16+ ASC-US or LSILStatus: Recruiting, Estimated PCD: 2024-06-30